We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Throughout the year, you will have the opportunity to participate in campaigns that support endocrinology research, care, professionals, and patients. Contact us to get more involved: [email protected].
The Endocrine Society is calling on Congress to pass provisions that would lower the price and consumer cost of insulin. There are several policy options that Congress could implement, ranging from allowing government negotiation of the price of insulin to other policies that would lower out-of-pocket costs for people with diabetes, such as copay caps, eliminating the deductible, and cost-sharing. The most important thing is that Congress acts now to address this issue and work on a solution that can be passed because people with diabetes cannot wait any longer for help.
The Endocrine Society is urging Congress to help researchers recover from the COVID-19 pandemic, restart their labs, and continue making progress on important research progress that was interrupted by the pandemic. The most promising vehicle for providing research relief through additional funds is the Research Investment to Spark the Economy (RISE) Act, which was introduced last year and has bipartisan support. The RISE Act would authorize approximately $25 billion in additional funds for research recovery, including nearly $10 billion for the NIH. While the bill has significant bipartisan support – they need more cosponsors to ensure that the Act makes it across the finish line!
Take action in our campaign and tell your Representative support the RISE Act so that our research community can recover from pandemic-related closures and other disruptions. Advocacy matters and if the research community is vocal about their needs, we can ensure that increased federal funds for research are consistent and sustainable.
Our advocacy calendar provides a global overview of upcoming legislative and regulatory deadlines and events.
Read our newsletters covering the latest science-based information on endocrine-disrupting chemicals (EDCs) for policymakers in the European Union.